Literature DB >> 24936319

Biological effects and equivalent doses in radiotherapy: A software solution.

Cyril Voyant1, Daniel Julian2, Rudy Roustit3, Katia Biffi4, Céline Lantieri4.   

Abstract

BACKGROUND: The limits of TDF (time, dose, and fractionation) and linear quadratic models have been known for a long time. Medical physicists and physicians are required to provide fast and reliable interpretations regarding delivered doses or any future prescriptions relating to treatment changes. AIM: We, therefore, propose a calculation interface under the GNU license to be used for equivalent doses, biological doses, and normal tumor complication probability (Lyman model).
MATERIALS AND METHODS: THE METHODOLOGY USED DRAWS FROM SEVERAL SOURCES: the linear-quadratic-linear model of Astrahan, the repopulation effects of Dale, and the prediction of multi-fractionated treatments of Thames. RESULTS AND
CONCLUSIONS: The results are obtained from an algorithm that minimizes an ad-hoc cost function, and then compared to an equivalent dose computed using standard calculators in seven French radiotherapy centers.

Entities:  

Keywords:  Fractionation; Linear quadratic; Radiobiology; Repopulation; Time effect

Year:  2013        PMID: 24936319      PMCID: PMC4055002          DOI: 10.1016/j.rpor.2013.08.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  20 in total

1.  [Radiobiology].

Authors:  V Favaudon
Journal:  Cancer Radiother       Date:  2000 Sep-Oct       Impact factor: 1.018

2.  [T.i.d. accelerated radiotherapy alone or alternating with chemotherapy in patients with a locally advanced ORL cancer: analysis of late toxicity].

Authors:  A Laszlo; A Rosset; F Hermann; M Ozsahin; A Zouhair; R O Mirimanoff
Journal:  Cancer Radiother       Date:  2001-04       Impact factor: 1.018

3.  Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.

Authors:  Melvin Astrahan
Journal:  Med Phys       Date:  2008-09       Impact factor: 4.071

Review 4.  [Radiation biology: major advances and perspectives for radiotherapy].

Authors:  A Joubert; G Vogin; C Devic; A Granzotto; M Viau; M Maalouf; C Thomas; C Colin; N Foray
Journal:  Cancer Radiother       Date:  2011-06-16       Impact factor: 1.018

Review 5.  [Radiosensitivity, radiocurability and DNA repair].

Authors:  G Vogin
Journal:  Cancer Radiother       Date:  2011-02-22       Impact factor: 1.018

6.  [Radiobiology: a multidisciplinary interface].

Authors:  E Deutsch; M-C Vozenin
Journal:  Cancer Radiother       Date:  2011-08       Impact factor: 1.018

Review 7.  The linear-quadratic formula and progress in fractionated radiotherapy.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  1989-08       Impact factor: 3.039

8.  [Radiobiological features of anti-cancer treatments involving synchrotron radiation: outcome and perspectives].

Authors:  N Foray
Journal:  Cancer Radiother       Date:  2010-02-26       Impact factor: 1.018

9.  Radiation-induced lung damage: dose-time-fractionation considerations.

Authors:  J Van Dyk; K Mah; T J Keane
Journal:  Radiother Oncol       Date:  1989-01       Impact factor: 6.280

10.  IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique.

Authors:  Vicente Bruzzaniti; Armando Abate; Massimo Pedrini; Marcello Benassi; Lidia Strigari
Journal:  J Exp Clin Cancer Res       Date:  2011-05-09
View more
  8 in total

1.  Relationships between various indices of doses distribution homogeneity.

Authors:  Marzena Mrozowska; Paweł Kukołowicz
Journal:  Rep Pract Oncol Radiother       Date:  2015-05-01

2.  Normal lung tissue complication probability in MR-Linac and conventional radiotherapy.

Authors:  Somayeh Gholami; Francesco Longo; Sara Shahzadeh; Hassan Ali Nedaie; Ryan Sharp; Ali S Meigooni
Journal:  Rep Pract Oncol Radiother       Date:  2020-09-29

3.  Isobio software: biological dose distribution and biological dose volume histogram from physical dose conversion using linear-quadratic-linear model.

Authors:  Tanwiwat Jaikuna; Phatchareewan Khadsiri; Nisa Chawapun; Suwit Saekho; Ekkasit Tharavichitkul
Journal:  J Contemp Brachytherapy       Date:  2017-02-20

4.  Establishment of a New Three-Dimensional Dose Evaluation Method Considering Variable Relative Biological Effectiveness and Dose Fractionation in Proton Therapy Combined with High-Dose-Rate Brachytherapy.

Authors:  Daisuke Kobayashi; Tomonori Isobe; Kenta Takada; Yutaro Mori; Hideyuki Takei; Hiroaki Kumada; Satoshi Kamizawa; Tetsuya Tomita; Eisuke Sato; Hiroshi Yokota; Takeji Sakae
Journal:  J Med Phys       Date:  2019-12-11

Review 5.  Design Principles of Hybrid Nanomaterials for Radiotherapy Enhanced by Photodynamic Therapy.

Authors:  Valeria Secchi; Angelo Monguzzi; Irene Villa
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

6.  Comparison of breast sequential and simultaneous integrated boost using the biologically effective dose volume histogram (BEDVH).

Authors:  Moamen M O M Aly; Yasser Abo-Madyan; Lennart Jahnke; Frederik Wenz; Gerhard Glatting
Journal:  Radiat Oncol       Date:  2016-02-02       Impact factor: 3.481

7.  Voxel based BED and EQD2 Evaluation of the Radiotherapy Treatment Plan.

Authors:  Gaganpreet Singh; Arun S Oinam; Rose Kamal; Bhumika Handa; Vivek Kumar; Bhavana Rai
Journal:  J Med Phys       Date:  2018 Jul-Sep

8.  Dosimetric Comparison of Ultra-Hypofractionated and Conventionally Fractionated Radiation Therapy Boosts for Patients with High-Risk Prostate Cancer.

Authors:  Tomasz Piotrowski; Slav Yartsev; Jaroslaw Krawczyk; Marta Adamczyk; Agata Jodda; Julian Malicki; Piotr Milecki
Journal:  Life (Basel)       Date:  2022-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.